Bhushan Kapur

I graduated with a D.Phil. from the University of Basel, Switzerland in 1967. I was the Director of Laboratories at the Addiction Research Foundation from 1971 to May 1995. From May 1995 to December 2015, I was with the Division of Clinical Pharmacology and Toxicology, Sick Children Hospital in Toronto. I was appointed consultant in the Department of Clinical Pathology, Sunnybrook Health Science Centre and in 2008 a Research Associate in the Sunnybrook Research Institute. From August 2001 to November 2005, I was responsible for the direction of the toxicology laboratory at the St. Michael’s Hospital in Toronto.

MSc thesis supervisor of 14 students and examiner of 11 MSc thesis. PhD supervisor and committee member of 20 students and PhD examiner of 17 students.

I retired as Associate Professor in the Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto March 2015. I am also Chartered Chemist and Fellow of The Royal Society of Chemistry (UK); Fellow of Academy of Clinical Biochemistry (USA) and Canadian Academy of Clinical Biochemistry (CAN).

Sarah Delaney

Sarah Delaney is a Clinical Biochemist at Unity Health Toronto - St. Michael's Hospital. Sarah completed her PhD in Pharmacology and Toxicology at the University of Toronto and her Clinical Chemistry Fellowship at Mayo Clinic in Rochester, MN.

Francis Lin

Francis Lin did his Ph.D. in biophysics and biomedical engineering at the University of California-Irvine. This was followed by postdoctoral research at Stanford University School of Medicine. Francis then joined the University of Manitoba and is currently a tenured Full Professor in Physics, Immunology and Biological Sciences. His lab studies environmental guiding mechanisms for the migration of different biological cells with the focus on chemical and electrical cues using a combination of microfluidic devices, quantitative modeling and cell biology and immunology approaches. In addition, his lab has been developing lab-on-chip tools for a range of biological and biomedical applications, particularly point-of-care diagnostic applications for chronic diseases. Francis’ past and current research has been supported by training fellowships from NIH and grants from Stanford Bio-X, the University of Manitoba, and various Canadian funding agencies such as NSERC, CIHR, CFI and Research Manitoba. He has been on the executive team of the Division of Physics in Medicine and Biology for the Canadian Association of Physicists, and served as the division chair for 2018-2019.

Edward Randell

Dr. Edward Randell is the Division Chief of Clinical Biochemistry at Eastern Health Authority, Professor of Laboratory Medicine with the Faculty of Medicine at Memorial University, and Director of Clinical Laboratories with Ministry of Health (Government of Newfoundland and Labrador) in the Province of Newfoundland and Labrador. He has worked almost 25 years as a Clinical Biochemist, and is actively involves in CSCC and IFCC activities. His research activities to date have led to over 100 articles in peer-reviewed journals focusing on clinical biochemistry, obesity, diabetes, and arthritis. He is also a Six Sigma black belt and has professional interests in quality management, process improvement, and improving laboratory test utilization.

Jan Palaty

Jan Palaty obtained a PhD in Pharmaceutical Sciences from the University of BC in 1995 and his CACB certification in 2001. He has since been employed at WorkSafeBC, BC Children's Hospital and LifeLabs (or its subsidiary, the former BC Biomedical), with a particular interest in analytical toxicology and mass spectrometry.

Ivan Blasutig

Dr. Blasutig completed his HonBSc and PhD in Molecular Genetics and Molecular Biology and post-doctoral training in Clinical Biochemistry at the University of Toronto. He was an Academic Clinical Biochemist at the University Health Network for several years and had oversight of the Immunology area of the Biochemistry laboratory.

He is currently working for EORLA as CHEO’s Chief, Division of Biochemistry and Laboratory Director for the EORLA labs at CHEO and the Winchester District Memorial Hospital. He is the Chair of the EORLA Quality Committee, whose function is to lead and promote excellence of quality in Laboratory Medicine across all 18 EORLA laboratories.

Zahraa Mohammed-Ali

Zahraa completed her both her undergraduate and graduate degrees from McMaster University. After her Ph.D. she pursued post-doctoral research work in mass spectrometry where she established a non-invasive proteomics assay for the early detection of fibrosis in renal transplant recipients. She recently completed her training at the University of Toronto clinical chemistry program where she developed an interest in quality improvement in Healthcare.

Miranda Brun

Miranda Brun has a B.Sc in Biochemistry from the University of Alberta. She completed her PhD in Experimental Oncology at the University of Alberta in 2015. Miranda completed a fellowship in clinical biochemistry at the University of Alberta in June, 2020. Miranda is a clinical biochemist at Alberta Precision Laboratories and an assistant professor in the Department of Laboratory Medicine and Pathology at the University of Alberta.

Mathieu Provencal

In January 2011, Dr. Provençal joined the Maisonneuve-Rosemont Hospital where he worked since as a clinical biochemist. Since 2016, he is in charge of all the POCT use in the hospital and community settings for the eastern part of Montreal.

In the private sector, in 2011, he co-founded an IVF Clinic, and acted as director of the laboratory until October 2014. In 2013, Dr. Provençal published the book: Design, for the general public and dealing with the difficult issue of infertility. The book was translated into English and Chinese.

From 2015 to 2018, he setup a private lab in Quebec to support the Jonhson&Jonhson patient support program for patients suffering from Inflammatory bowel diseases.

Dr Provençal is also involved since 2013 with Accreditation Canada as a surveyor.